0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover212.32%IV-54.49%PremiumDec 20, 2024Expiry Date8.98Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9511Delta0.0106Gamma1.78Leverage Ratio-0.0185Theta0.0048Rho1.69Eff Leverage0.0045Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet